Helius Medical Technologies Inc (HMT) is a medical device company. It provides neurological wellness solutions. The company development, licensing and acquisition of non-invasive platform technologies for amplifying the brain’s ability to heal itself. It provides the development of technologies as a potential treatment for neurological symptoms caused by disease or trauma. HMT provides a portable neuromodulation stimulator (PoNS) device, an investigational device in development, that enables physicians and patients to manage a host of neurological symptoms. The company offers devices that use results from the planned pivotal, multi-center mTBI study to support an application to the FDA for commercial distribution. HMT is headquartered in Newtown, Pennsylvania, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Helius Medical Technologies Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
- Helius Medical Technologies Inc Company Overview
- Helius Medical Technologies Inc Company Snapshot
- Helius Medical Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- Helius Medical Technologies Inc - Pipeline Analysis Overview
- Helius Medical Technologies Inc - Key Facts
- Helius Medical Technologies Inc - Major Products and Services
- Helius Medical Technologies Inc Pipeline Products by Development Stage
- Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
- Helius Medical Technologies Inc Pipeline Products Overview
- PoNS Device - Chronic Balance Disorder
- PoNS Device - Chronic Balance Disorder Product Overview
- PoNS Device - Depression
- PoNS Device - Depression Product Overview
- PoNS Device - Facial Nerve Palsy
- PoNS Device - Facial Nerve Palsy Product Overview
- PoNS Device - Parkinson’s Disease
- PoNS Device - Parkinson’s Disease Product Overview
- PoNS Device - PTSD
- PoNS Device - PTSD Product Overview
- PoNS Device - Stroke
- PoNS Device - Stroke Product Overview
- PoNS Device - Stroke Clinical Trial
- Helius Medical Technologies Inc - Key Competitors
- Helius Medical Technologies Inc - Key Employees
- Helius Medical Technologies Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Helius Medical Technologies Inc, Recent Developments
- Nov 18, 2024: Helius Medical Technologies Announces Exploration of Strategic Alternatives
- Nov 18, 2024: Helius Medical Technologies Provides Updates on Efforts to Achieve Fair Market Access for its Portable Neuromodulation Stimulator (PoNS) Device
- Sep 30, 2024: Helius Medical Technologies Announces Positive Preliminary Results of the PoNSTEP Study
- Aug 06, 2024: Helius Medical Technologies to Release Second Quarter 2024 Financial Results on August 12, 2024
- Jun 17, 2024: Helius Medical Technologies, Completes Site Participation Enrollment for its U.S. Registrational Program in Stroke
- May 29, 2024: Helius Medical Technologies Announces Third-Party Reimbursement for PoNS from Major Insurance Carrier
- May 23, 2024: Helius Medical Technologies To Exhibit At 2024 CMSC Annual Meeting, Marking A Year Of Achievements: Making Pons More Available To People With MS
- May 20, 2024: Helius Medical Technologies Announces PoNS Is Now Available on the Veterans Affairs (VA) Federal Supply Schedule (FSS) and General Services Administration (GSA) Advantage Contracts
- May 06, 2024: Helius Medical Technologies, Announces Preliminary CMS Payment Determination of Reimbursement for Portable Neuromodulation Stimulator (PoNS)
- Apr 03, 2024: Helius Medical Technologies, Announces Partnership with Lovell Government Services to Expand Reach of Pons Therapy
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Helius Medical Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
- Helius Medical Technologies Inc Pipeline Products by Equipment Type
- Helius Medical Technologies Inc Pipeline Products by Indication
- Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
- Helius Medical Technologies Inc, Key Facts
- Helius Medical Technologies Inc, Major Products and Services
- Helius Medical Technologies Inc Number of Pipeline Products by Development Stage
- Helius Medical Technologies Inc Pipeline Products Summary by Development Stage
- Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
- Helius Medical Technologies Inc Ongoing Clinical Trials Summary
- PoNS Device - Chronic Balance Disorder - Product Status
- PoNS Device - Chronic Balance Disorder - Product Description
- PoNS Device - Depression - Product Status
- PoNS Device - Depression - Product Description
- PoNS Device - Facial Nerve Palsy - Product Status
- PoNS Device - Facial Nerve Palsy - Product Description
- PoNS Device - Parkinson’s Disease - Product Status
- PoNS Device - Parkinson’s Disease - Product Description
- PoNS Device - PTSD - Product Status
- PoNS Device - PTSD - Product Description
- PoNS Device - Stroke - Product Status
- PoNS Device - Stroke - Product Description
- PoNS Device - Stroke - A Study to Evaluate the Effects of Cranial-Nerve Non-invasive Neuromodulation Delivered Through PoNS Therapy for Gait and Dynamic Balance in Chronic Stroke Survivors
- PoNS Device - Stroke - Cranial-nerve Non-invasive Neuromodulation and Dynamic Balance in Chronic Stroke Survivors
- PoNS Device - Stroke - Portable Neuromodulation Stimulator (PoNS) Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Randomized Controlled Trial.
- PoNS Device - Stroke - Portable Neuromodulation Stimulator (PoNS) Therapy for Gait and Balance Deficits in Chronic Stroke Survivors: A Single-Arm Study
- Helius Medical Technologies Inc, Key Employees
- Helius Medical Technologies Inc, Subsidiaries
- Glossary
- Helius Medical Technologies Inc Pipeline Products by Equipment Type
- Helius Medical Technologies Inc Pipeline Products by Development Stage
- Helius Medical Technologies Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Candela Medical Inc
- Osprey Medical Inc
- Cytta Corp
- Airxpanders, Inc.
- D&K Healthcare Resources, Inc.
